Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410132 | 12541013 | 2 | F | 201605 | 20160907 | 20160708 | 20160915 | EXP | US-JNJFOC-20160705934 | JANSSEN | 65.77 | YR | A | F | Y | 79.83000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410132 | 12541013 | 1 | SS | INVOKANA | CANAGLIFLOZIN | 1 | Oral | Y | U | 0 | 300 | MG | TABLET | QD | |||||
| 125410132 | 12541013 | 2 | PS | INVOKANA | CANAGLIFLOZIN | 1 | Oral | Y | U | 204042 | 300 | MG | TABLET | QD | |||||
| 125410132 | 12541013 | 3 | SS | VICTOZA | LIRAGLUTIDE | 1 | Unknown | U | 0 | 18 | MG | UNSPECIFIED | |||||||
| 125410132 | 12541013 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | 750 | MG | UNSPECIFIED | BID | ||||||
| 125410132 | 12541013 | 5 | C | INSULIN BASAL | INSULIN NOS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125410132 | 12541013 | 6 | C | SPIRO | 2 | Unknown | SINCE YEARS | 0 | 100 | MG | UNSPECIFIED | ||||||||
| 125410132 | 12541013 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | SINCE YEARS | 0 | 25 | IU | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125410132 | 12541013 | 1 | Type 2 diabetes mellitus |
| 125410132 | 12541013 | 2 | Type 2 diabetes mellitus |
| 125410132 | 12541013 | 3 | Type 2 diabetes mellitus |
| 125410132 | 12541013 | 4 | Type 2 diabetes mellitus |
| 125410132 | 12541013 | 6 | Hypertension |
| 125410132 | 12541013 | 7 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125410132 | 12541013 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125410132 | 12541013 | Diabetic ketoacidosis | |
| 125410132 | 12541013 | Kidney infection | |
| 125410132 | 12541013 | Urinary tract infection | |
| 125410132 | 12541013 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125410132 | 12541013 | 1 | 20160706 | 0 | ||
| 125410132 | 12541013 | 2 | 20140709 | 201605 | 0 | |
| 125410132 | 12541013 | 3 | 2013 | 0 | ||
| 125410132 | 12541013 | 4 | 2011 | 0 |